Breaking News

Evonik Increases Capacity for Plant-derived Cholesterol

Extra production capacity for PhytoChol at German site for mRNA vaccines and gene therapies.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Evonik has boosted its supply of plant-derived cholesterol, one of the most critical components for the manufacture of mRNA vaccines and gene therapies. The large-scale production of PhytoChol in Hanau, Germany, will meet an increased market demand for cholesterol. This lipid is one of the key excipients in the lipid nanoparticles (LNPs) used in COVID-19 vaccines. Rapid advances in research make lipid-based drug delivery increasingly relevant for a broader range of therapeutics, including vaccin...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters